Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.57−0.27 (-14.40%)
Close on Nov 16, 2026Market cap $2.50MP/E –Yield –
Silo Pharma total assets
Total assets on the balance sheet at the end of each period.
Silo Pharma's total assets was $5.95M at Jun 30, 2026. For fiscal 2025 it was $7.61M, up 2.6% from the year before. Over ten years it grew 177.7% a year on average. The highest annual figure on record is $11.64M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.61M | +2.6% |
| FY2024 | Dec 31, 2024 | $7.41M | -4.3% |
| FY2023 | Dec 31, 2023 | $7.75M | -33.5% |
| FY2022 | Dec 31, 2022 | $11.64M | +11.0% |
| FY2021 | Dec 31, 2021 | $10.49M | +635.3% |
| FY2020 | Dec 31, 2020 | $1.43M | +188.9% |
| FY2019 | Dec 31, 2019 | $493.85K | -42.3% |
| FY2018 | Dec 31, 2018 | $855.42K | -47.9% |
| FY2017 | Dec 31, 2017 | $1.64M | -25.6% |
| FY2013 | Dec 31, 2013 | $2.21M | +791077.1% |
| FY2012 | Dec 31, 2012 | $279 | -84.1% |
| FY2011 | Dec 31, 2011 | $1.75K | -96.3% |
| FY2010 | Dec 31, 2010 | $47.48K | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $5.95M | -10.5% |
| Q1 FY2026 | Mar 31, 2026 | $7.02M | +19.0% |
| Q4 FY2025 | Dec 31, 2025 | $7.61M | +2.6% |
| Q3 FY2025 | Sep 30, 2025 | $6.38M | -25.5% |
| Q2 FY2025 | Jun 30, 2025 | $6.65M | -17.2% |
| Q1 FY2025 | Mar 31, 2025 | $5.90M | -23.8% |
| Q4 FY2024 | Dec 31, 2024 | $7.41M | -17.5% |
| Q3 FY2024 | Sep 30, 2024 | $8.57M | -16.4% |
| Q2 FY2024 | Jun 30, 2024 | $8.04M | -31.0% |
| Q4 FY2023 | Dec 31, 2023 | $7.75M | -40.6% |
| Q3 FY2023 | Sep 30, 2023 | $8.99M | -0.6% |
| Q1 FY2023 | Jun 30, 2023 | $10.25M | +5.5% |
| Q4 FY2022 | Dec 31, 2022 | $11.64M | +11.0% |
| Q3 FY2022 | Sep 30, 2022 | $13.05M | +14.6% |
| Q2 FY2022 | Jun 30, 2022 | $9.04M | +80.8% |
| Q1 FY2022 | Mar 31, 2022 | $9.72M | +76.6% |
| Q4 FY2021 | Dec 31, 2021 | $10.49M | +635.3% |
| Q3 FY2021 | Sep 30, 2021 | $11.39M | +416.8% |
| Q2 FY2021 | Jun 30, 2021 | $5.00M | +79.0% |
| Q1 FY2021 | Mar 31, 2021 | $5.50M | +1262.3% |
| Q4 FY2020 | Dec 31, 2020 | $1.43M | +188.9% |
| Q3 FY2020 | Sep 30, 2020 | $2.20M | +470.2% |
| Q2 FY2020 | Jun 30, 2020 | $2.80M | +422.1% |
| Q1 FY2020 | Mar 31, 2020 | $403.82K | -46.2% |
| Q4 FY2019 | Dec 31, 2019 | $493.85K | -42.3% |
| Q3 FY2019 | Sep 30, 2019 | $386.53K | -73.1% |
| Q2 FY2019 | Jun 30, 2019 | $535.54K | -67.4% |
| Q1 FY2019 | Mar 31, 2019 | $750.85K | -66.0% |
| Q4 FY2018 | Dec 31, 2018 | $855.42K | +132.0% |
| Q3 FY2018 | Sep 30, 2018 | $1.44M | +14116.0% |
| Q4 FY2017 | Dec 31, 2017 | $1.64M | +588210.0% |
| Q4 FY2013 | Dec 31, 2013 | $2.21M | +791077.1% |
| Q2 FY2013 | Jun 30, 2013 | $368.68K | – |
| Q1 FY2013 | Mar 31, 2013 | $10.10K | – |
| Q4 FY2012 | Dec 31, 2012 | $279 | – |
| Q3 FY2012 | Sep 30, 2012 | $279 | – |
See a number that looks wrong?